ArticleAesthetic plastic surgery2026
Potential of Hair Follicle Stem Cell-Derived Exosomes Carrying miR-181a-5p to Promote the Telogen-to-Anagen Stage.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundHair loss is a common clinical and aesthetic concern, and existing treatments remain limited by side effects, invasiveness, or unsatisfactory long-term efficacy. Stem cell-derived exosomes have emerged as a promising cell-free strategy for tissue regeneration. However, the hair-regenerative potential of hair follicle stem cell-derived exosomes (HFSC-Exos), particularly when enriched with miR-181a-5p, remains insufficiently explored.
methodsCommercially available rat hair follicle stem cells (HFSCs) were cultured, and exosomes were isolated from cells at passages 3-4 after transfection with miR-181a-5p mimics or negative control mimics. Exosomes were characterized by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blotting. Twenty 7-week-old C57BL/6 mice, which were generally in telogen at this age, were randomly assigned to four groups (n = 5/group): PBS, Exos, Exos
resultsHFSC-Exos accelerated the transition from telogen to anagen and promoted visible hair regrowth compared with PBS treatment. Among all groups, Exos
conclusionHFSC-Exos promoted the telogen-to-anagen transition and hair regrowth in vivo. Enrichment of miR-181a-5p enhanced this effect and was associated with activation of the Wnt/β-catenin pathway, although direct target validation remains to be established. NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42562897What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.